LATEST NEWS
MHRA Approves Phase I/II Clinical Trial of IN3BIO Vaccine to Improve Outcomes for Colorectal Cancer Patients
March 9, 2022 – IN3BIO Research Limited, a leader in developing cancer treatments that, based upon clinical data, show significant…
IN3BIO gains approval for Phase I/II clinical trial
June 8, 2021 – IN3BIO Research Limited announced today that the company has received the Clinical Trial Application approval from…
Pangaea Oncology Signs 1.1 Mln contract with In3BIO
July 8, 2020 (Reuters) – Pangaea Oncology SA: Source: https://uk.reuters.com/article/idUKL8N2EF4DZ
